Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke
نویسندگان
چکیده
Circulating neutrophil extracellular traps (NETs) resistant to t-PA have not been studied completely although NETs in thrombi may contribute tissue plasminogen activator (t-PA) resistance. This research intended elucidate whether circulating are associated with resistance and the underlying mechanism. The levels of were detected neutrophils, ischemic brain acute stroke (AIS) patients, transient middle cerebral artery occlusion (tMCAO) models. NET formation blood, thrombi, mice analyzed by immunofluorescence. Exposed phosphatidylserine (PS) was assessed using flow cytometry confocal microscopy. Procoagulant activity (PCA) evaluated fibrin assays, thrombin, purified coagulation complex. plasma AIS patients significantly higher than those healthy individuals. After thrombolysis, a significant increase noted markers no-improvement while changes improvement significant. Importantly, decorated von Willebrand factor (vWF) inhibitor-1 (PAI-1) blood which could reverse fibrinolytic effects. In addition, activated platelets (PLTs) endothelial cells (ECs), stimulating procoagulant phenotype facilitating vWF PAI-1 release. DNase I, protein C (APC), sivelestat markedly inhibited these Furthermore, targeting protected from tMCAO-induced ischemia, possibly regulating PAI-1. summary, through activation PLTs ECs. Strategies against present promising therapeutic approach improve thrombolysis efficiency patients.
منابع مشابه
The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...
متن کاملpharmacotherapy updates of recombinant tissue plasminogen activator (r-tpa) in acute ischemic stroke
conclusions due to considerable inter- and intra- heterogeneity among studies performed by other centers such as differences in study project, background, and population features, determining a pharmacotherapy model based on safe implementation of treatments in stroke or sits seem advantageous. results age, time of onset, systolic blood pressure, diabetes, stroke severity, co-morbidities and pr...
متن کاملTissue-type plasminogen activator for acute ischemic stroke.
BACKGROUND AND PURPOSE Several studies are currently evaluating tissue-type plasminogen activator (TPA) as a potential therapy in acute ischemic stroke. The possibility of inducing intracranial hematomas, however, introduces an important concern into ultimate evaluation of risk and benefit. This retrospective analysis sought to identify factors associated with intracranial hematoma formation in...
متن کاملCost-effectiveness of tissue plasminogen activator for acute ischemic stroke.
Dates to which data relate Effectiveness and resource use data were extracted from NINDS rt-PA Stroke Trial conducted between January 1991 and October 1994, the results of which were published in 1995. Clinical probabilities relating to the epidemiological course of events were obtained from studies published between 1982 and 1997. The utility values related to different discharge states were b...
متن کاملLow-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.
BACKGROUND The burden of stroke is becoming an important issue in Asian countries, where half of the world's population lives. In Western populations, standard-dose intravenous tissue plasminogen activator (tPA) at a dose of 0.9 mg/kg administered up to 4.5 h following acute ischaemic stroke has been shown to improve clinical outcomes. However, the dosage of tPA in Asian populations varies, par...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The FASEB Journal
سال: 2021
ISSN: ['0892-6638', '1530-6860']
DOI: https://doi.org/10.1096/fj.202100471rr